Well-differentiated duodenal tumor/carcinoma (excluding gastrinomas)

Neuroendocrinology

Volumn 84, Issue 3, 2006, Pages 165-172

  Jensen, Robert T ^a,m   Rindi, Guido ^b   Arnold, Rudolf ^c   Lopes, José M ^d   Brandi, Maria Luisa ^e   Bechstein, Wolf O ^f   Christ, Emanuel ^g   Taal, Babs G ^h   Knigge, Ulrich ⁱ   Ahlman, Hakan ^j   Kwekkeboom, Dik J ^k   O'Toole, Dermot ^l   Cadiot, G ⁿ   Caplin, M ^o   Chung, D ^p   Couvelard, A ^l   De Herder, W W ^k   Delle Fave, G ^q   Eriksson, B ^r   Falchetti, A ^e   Falconi, M ^s   Ferone, D ^t   Goretzki, P ^u   Gross, D ^v   Hochhauser, D ^w   Hyrdel, R ^x   Kaltsas, G ^y   Kelestimur F ^z   Kianmanesh, R ^aa   Knapp, W ^ab   Komminoth, P ^ac   Korner M ^ad   Kos Kudla B ^ae   Kvols, L ^af   Lewington, V ^ag   Manfredi, R ^ah   McNicol, A M ^ai   Mitry, E ^aj   Niederle, B ^ak   Nikou, G ^al   Nilsson, O ^j   Oberg K ^r   O'Connor, J ^am   Pauwels, S ^an   Pape, U F ^ao   Pavel, M ^ap   Perren, A ^aq   Plockinger U ^ar   Ramage, J ^as   Ricke, J ^ar   Ruszniewski, P ^l   Salazar, R ^at   Sauvanet, A ^l   Scarpa, A ^s   Scoazec, J Y ^au   Sevilla Garcia, M I ^av   Steinmuller T ^aw   Sundin, A ^ax   Van Cutsem, E ^ay   Vullierme, M P ^l   Wiedenmann, B ^as   Wildi, S ^az   Yao, J C ^ba   Zgliczynski, S ^bb   more..

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF PARMA   (Italy)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d UNIVERSITY OF PORTO   (Portugal)

^e UNIVERSITY OF FLORENCE   (Italy)

^f GOETHE UNIVERSITY   (Germany)

^g UNIVERSITY OF BERN   (Switzerland)

^h Netherlands Cancer Centre   (Netherlands)

ⁱ Rigshospitalet   (Denmark)

^j UNIVERSITY OF GOTHENBURG   (Sweden)

^k ERASMUS MEDICAL CENTER   (Netherlands)

^l BEAUJON HOSPITAL   (France)

^m NATIONAL INSTITUTES OF HEALTH   (United States)

ⁿ BICHAT HOSPITAL   (France)

^o ROYAL FREE HOSPITAL   (United Kingdom)

^p MASSACHUSETTS GENERAL HOSPITAL   (United States)

^q SAPIENZA UNIVERSITY OF ROME   (Italy)

^r UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^s UNIVERSITY OF VERONA   (Italy)

^t UNIVERSITY OF GENOA   (Italy)

^u Lukaskrankenhaus GmbH   (Germany)

^v HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^w UNIVERSITY COLLEGE LONDON   (United Kingdom)

^x Martin University   (Slovakia)

^y Genimatas Hospital   (Greece)

^z ERCIYES UNIVERSITY   (Turkey)

^aa HÔPITAL LOUIS MOURIER   (France)

^ab HANNOVER MEDICAL SCHOOL   (Germany)

^ac Kantonsspital Baden   (Switzerland)

^ad UNIVERSITY OF BERN   (Switzerland)

^ae SILESIAN UNIVERSITY OF TECHNOLOGY   (Poland)

^af UNIVERSITY OF SOUTH FLORIDA   (United States)

^ag ROYAL MARSDEN HOSPITAL   (United Kingdom)

^ah Istituto di Radiologia   (Italy)

^ai GLASGOW ROYAL INFIRMARY   (United Kingdom)

^aj CHV A Pare Hospital   (France)

^ak UNIVERSITY OF VIENNA   (Austria)

^al LAIKO GENERAL HOSPITAL   (Greece)

^am INSTITUTO ALEXANDER FLEMING   (Argentina)

^an UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^ao HUMBOLDT UNIVERSITY   (Germany)

^ap UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^aq UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^ar CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^as NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

^at CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^au EDOUARD HERRIOT HOSPITAL   (France)

^av HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^aw VIVANTES HOSPITAL   (Germany)

^ax UPPSALA UNIVERSITY   (Sweden)

^ay UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^az UNIVERSITY HOSPITAL OF PSYCHIATRY ZURICH   (Switzerland)

^ba UNIVERSITY OF TEXAS   (United States)

^bb BIELANSKI HOSPITAL   (Poland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CARBOPLATIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; SOMATOSTATIN; STREPTOZOCIN;

CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL FEATURE; CONFERENCE PAPER; CONSENSUS; DUODENUM CARCINOMA; DUODENUM TUMOR; ENDOSCOPY; FOLLOW UP; GENETICS; HUMAN; LABORATORY TEST; LAPAROSCOPY; NUCLEAR MEDICINE; PANCREATICODUODENECTOMY; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS;

EID: 33847624540     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098008     Document Type: Conference Paper

References (94)

1. Kloppel G, Perren A, Heitz PU: The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann NY Acad Sci 2004;1014:13-27.
2. Attanoos R, Williams GT: Epithelial and neuroendocrine tumors of the duodenum. Semin Diagn Pathol 1991;8:149-162.
3. Jensen RT, Doherty GM: Carcinoid tumors and the carcinoid syndrome; in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology. Philadelphia, Lippincott Williams & Wilkins, 2001, pp 1813-1833.
4. Hoffmann KM, Furukawa M, Jensen RT: Duodenal neuroendocrine tumors: classification, functional syndromes, diagnosis and medical treatment. Best Pract Res Clin Gastroenterol 2005;19:675-697.
5. Soga J, Yakuwa Y: Duodenal carcinoids: a statistical evaluation of 635 cases collected from the literature. J Exp Clin Cancer Res 1996;15:3-10.
6. Burke AP, Federspiel BH, Sobin LH, Shekitka KM, Helwig EB: Carcinoids of the duodenum. A histologic and immunohistochemical study of 65 tumors. Am J Surg Pathol 1989;13:828-837.
7. Williams ED, Sandler M: The classification of carcinoid tumours. Lancet 1963;1:238-239.
8. Modlin IM, Lye KD, Kidd M: A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934-959.
9. Spinazzola AJ, Gillesby WJ: Primary malignant neoplasms of the duodenum: report of twelve cases. Am Surg 1963;29:405-412.
10. Witzigmann H, Loracher C, Geissler F, Wagner T, Tannapfel A, Uhlmann D, Caca K, Hauss J, Hehl A: Neuroendocrine tumours of the duodenum: clinical aspects, pathomorphology and therapy. Langenbecks Arch Surg 2002;386:525-533.
11. Bornstein-Quevedo L, Gamboa-Dominguez A: Carcinoid tumors of the duodenum and ampulla of Vater: a clinicomorphologic, immunohistochemical, and cell kinetic comparison. Hum Pathol 2001;32:1252-1256.
12. Walton GF, Gibbs ER, Spencer GO, Laws HL: Carcinoid tumors of the ampulla of Vater. Am Surg 1997;63:302-304.
13. Hatzitheoklitos E, Buchler MW, Friess H, Poch B, Ebert M, Mohr W, Imaizumi T, Beger HG: Carcinoid of the ampulla of Vater: clinical characteristics and morphologic features. Cancer 1994;73:1580-1588.
14. Clements WM, Martin SP, Stemmerman G, Lowy AM: Ampullary carcinoid tumors: rationale for an aggressive surgical approach. J Gastrointest Surg 2003;7:773-776.
15. Hartel M, Wente MN, Sido B, Friess H, Büchler MW: Carcinoid of the ampulla of Vater. J Gastroenterol Hepatol 2005;20:676-681.
16. Soga J, Yakuwa Y: Somatostatinoma/inhibitory syndrome: a statistical evaluation of 173 reported cases as compared to other pancreatic endocrinomas. J Exp Clin Cancer Res 1999;18:13-22.
17. Taccagni GL, Carlucci M, Sironi M, Cantaboni A, DiCarlo V: Duodenal somatostatinoma with psammoma bodies: an immunohistochemical and ultrastructural study. Am J Gastroenterol 1986;81:33-37.
18. Green BT, Rockey DC: Duodenal somatostatinoma presenting with complete somatostatinoma syndrome. J Clin Gastroenterol 2001;33:415-417.
19. Swinburn BA, Yeong ML, Lane MR, Nicholson GI, Holdaway IM: Neurofibromatosis associated with somatostatinoma: a report of two patients. Clin Endocrinol (Oxf) 1988;28:353-359.
20. Jensen RT: Endocrine tumors of the pancreas; in Yamada T, Alpers DH, Kaplowitz N, Laine L, Owyang C, Powell DW (eds): Textbook of Gastroenterology. Philadelphia, Lippincott Williams & Wilkins, 2003, pp 2108-2146.
21. Weichert RF 3rd, Roth LM, Krementz ET, Hewitt RL, Drapanas T: Carcinoid-islet cell tumors of the duodenum. Am J Surg 1971;121:195-205.
22. Lasson A, Alwmark A, Nobin A, Sundler F: Endocrine tumors of the duodenum. Clinical characteristics and hormone content. Ann Surg 1983;197:393-398.
23. Alumets J, Sundler F, Falkmer S, Ljungberg O, Hakanson R, Martensson H, Nobin A, Lasson A: Neurohormonal peptides in endocrine tumors of the pancreas, stomach, and upper small intestine. I. An immunohistochemical study of 27 cases. Ultrastruct Pathol 1983;5:55-72.
24. Stamm B, Hedinger CE, Saremaslani P: Duodenal and ampullary carcinoid tumors. A report of 12 cases with pathological characteristics, polypeptide content and relation to MEN 1 syndrome and von Recklinghausen's disease (neurofibromatosis). Virchows Arch [A] 1986;408:475-489.
25. Burke AP, Sobin LH, Federspiel BH, Shekitka KM, Helwig EB: Carcinoid tumors of the duodenum: a clinicopathologic study of 99 cases. Arch Pathol Lab Med 1990;114:700-704.
26. Capella C, Riva C, Rindi G, Usellini L, Chiaravalli A, Solcia E: Endocrine tumors of the duodenum and upper jejunum: a study of 33 cases with clinico-pathological characteristics and hormone content. Hepatogastroenterology 1990;37:247-252.
27. Heymann MF, Hamy A, Triau S, Miraille E, Toquet C, Chomarat H, Cohen C, Maitre F, Le Bodie MF: Endocrine tumors of the duodenum. A study of 55 cases relative to clinicopathological features and hormone content. Hepatogastroenterology 2004;51:1367-1371.
28. Soga J: Endocrinocarcinomas (carcinoids and their variants) of the duodenum. An evaluation of 927 cases. J Exp Clin Cancer Res 2003;22:349-363.
29. Thom AK, Norton JA, Axiotis CA, Jensen RT: Location, incidence and malignant potential of duodenal gastrinomas. Surgery 1991;110:1086-1093.
30. Norton JA, Alexander HR, Fraker DL, Venzon DJ, Jensen RT: Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases or survival in patients with Zollinger-Ellison syndrome (ZES)? Ann Surg 2004;239:617-626.
31. Norton JA, Jensen RT: Current surgical management of Zollinger-Ellison syndrome (ZES) in patients without multiple endocrine neoplasia-type 1 (MEN1). Surg Oncol 2003;12:145-151.
32. Gibril F, Jensen RT: Advances in evaluation and management of gastrinoma in patients with Zollinger-Ellison syndrome. Curr Gastroenterol Rep 2005;7:114-121.
33. Zogakis TG, Gibril F, Libutti SK, Norton JA, White DE, Jensen RT, Alexander HR: Management and outcome of patients with sporadic gastrinomas arising in the duodenum. Ann Surg 2003;238:42-48.
34. Jensen RT, Gardner JD: Gastrinoma; in Go VLW, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA (eds): The Pancreas: Biology, Pathobiology and Disease. New York, Raven Press, 1993, pp 931-978.
35. Weber HC, Venzon DJ, Lin JT, Fishbein VA, Orbuch M, Strader DB, Gibril F, Metz DC, Fraker DL, Norton JA, Jensen RT: Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology 1995;108:1637-1649.
36. Yu F, Venzon DJ, Serrano J, Goebel SU, Doppman JL, Gibril F, Jensen RT: Prospective study of the clinical course, prognostic factors and survival in patients with long-standing Zollinger-Ellison syndrome. J Clin Oncol 1999;17:615-630.
37. Gibril F, Schumann M, Pace A, Jensen RT: Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 patients from the literature. Medicine 2004;83:43-83.
38. Jensen RT: Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1. J Intern Med 1998;243:477-488.
39. Norton JA, Fraker DL, Alexander HR, Venzon DJ, Doppman JL, Serrano J, Goebel SU, Peghini P, Roy PK, Gibril F, Jensen RT: Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 1999;341:635-644.
40. Burke AP, Helwig EB: Gangliocytic paraganglioma. Am J Clin Pathol 1985;92:1-9.
41. Cohen T, Zweig SJ, Tallis A, Tuazon R, Reich M: Paraganglioneuroma of the duodenum: report of a case with radiographic findings, angiographic findings and a review of the literature. Am J Gastroenterol 1981;75:197-203.
42. Makhlouf HR, Burke AP, Sobin LH: Carcinoid tumors of the ampulla of Vater: a comparison with duodenal carcinoid tumors. Cancer 1999;85:1241-1249.
43. Kirshbom PM, Kherani AR, Onaitis MW, Hata A, Kehoe TE, Feldman C, Feldman JM, Tyler DS: Foregut carcinoids: a clinical and biochemical analysis. Surgery 1999;126:1105-1110.
44. Zyromski NJ, Kendrick ML, Nagorney DM, Grant CS, Donohue JH, Farnell MB, Thompson GB, Farley DR, Sarr MG: Duodenal carcinoid tumors: how aggressive should we be? J Gastrointest Surg 2001;5:588-593.
45. Wang HY, Chen MJ, Yang TL, Chang MC, Chan YJ: Carcinoid tumor of the duodenum and accessory papilla associated with polycythemia vera. World J Gastroenterol 2005;11:3794-3796.
46. Amano S, Hazama F, Haebara H, Tsurusawa M, Kaito H: Ectopic ACTH-MSH producing carcinoid tumor with multiple endocrine hyperplasia in a child. Acta Pathol Jpn 1978;28:721-730.
47. Dayal Y, Tallberg KA, Nunnemacher G, DeLellis RA, Wolfe HJ: Duodenal carcinoids in patients with and without neurofibromatosis: a comparative study. Am J Surg Pathol 1986;10:348-357.
48. Maton PN, Miller DL, Doppman JL, Collen MJ, Norton JA, Vinayek R, Slaff JI, Wank SA, Gardner JD, Jensen RT: Role of selective angiography in the management of Zollinger-Ellison syndrome. Gastroenterology 1987;92:913-918.
49. Mullen JT, Wang H, Yao JC, Lee JH, Perrier ND, Pisters PW, Lee JE, Evans DB: Carcinoid tumors of the duodenum. Surgery 2005;138:971-977.
50. Orbuch M, Doppman JL, Strader DB, Fishbeyn VA, Benya RV, Metz DC, Jensen RT: Imaging for pancreatic endocrine tumor localization: recent advances; in Mignon M, Jensen R T (eds): Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. Front Gastrointest Res. Basel, Karger, 1995, vol 23, pp 268-281.
51. Norton JA, Doppman JL, Jensen RT: Curative resection in Zollinger-Ellison syndrome: results of a 10-year prospective study. Ann Surg 1992;215:8-18.
52. Alexander HR, Fraker DL, Norton JA, Barlett DL, Tio L, Benjamin SB, Doppman JL, Goebel SU, Serrano J, Gibril F, Jensen RT: Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome. Ann Surg 1998;228:228-238.
53. Frucht H, Doppman JL, Norton JA, Miller DL, Dwyer AJ, Frank JA, Vinayek R, Maton PN, Jensen RT: Gastrinomas: comparison of MR Imaging with CT, angiography and US. Radiology 1989;171:713-717.
54. Gibril F, Jensen RT: Diagnostic uses of radiolabelled somatostatin-receptor analogues in gastroenteropancreatic endocrine tumors. Dig Liver Dis 2004;36:S106-S120.
55. Acs G, McGrath CM, Gupta PK: Duodenal carcinoid tumor: report of a case diagnosed by endoscopic ultrasound-guided fine-needle aspiration biopsy with immunocytochemical correlation. Diagn Cytopathol 2000;23:183-186.
56. Yoshikane H, Tsukamoto Y, Niwa Y, Goto H, Hase S, Mizutani K, Nakamura T: Carcinoid tumors of the gastrointestinal tract: evaluation with endoscopic ultrasonography. Gastrointest Endosc 1993;39:375-383.
57. Dalenback J, Havel G: Local endoscopic removal of duodenal carcinoid tumors. Endoscopy 2004;36:651-655.
58. Yoshikane H, Suzuki T, Yoshioka N, Ogawa Y, Hamajima E, Hasegawa N, Hasegawa C: Duodenal carcinoid tumor: endosonographic imaging and endoscopic resection. Am J Gastroenterol 1995;90:642-644.
59. Yoshikane H, Goto H, Niwa Y, Matsui M, Ohashi S, Suzuki T, Hamajima E, Hayakawa T: Endoscopic resection of small duodenal carcinoid tumors with strip biopsy technique. Gastrointest Endosc 1998;47:466-470.
60. Norton JA, Jensen RT: Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome. Ann Surg 2004;240:757-773.
61. Proye C, Malvaux P, Pattou F, Filoche B, Godchaux JM, Maunoury V, Palazzo L, Huglo D, Lefebvre J, Paris JC: Noninvasive imaging of insulinomas and gastrinomas with endoscopic ultrasonography and somatostatin receptor scintigraphy. Surgery 1998;124:1134-1144.
62. Ruszniewski P, Amouyal P, Amouyal G, Grange JD, Mignon M, Bouch O, Bernades P: Localization of gastrinomas by endoscopic ultrasonography in patients with Zollinger-Ellison syndrome. Surgery 1995;117:629-635.
63. Gibril F, Reynolds JC, Doppman JL, Chen CC, Venzon DJ, Termanini B, Weber HC, Stewart CA, Jensen RT: Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas: a prospective study. Ann Intern Med 1996;125:26-34.
64. Termanini B, Gibril F, Reynolds JC, Doppman JL, Chen CC, Stewart CA, Sutliff V, Jensen RT: Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management. Gastroenterology 1997;112:335-347.
65. Gibril F, Doppman JL, Reynolds JC, Chen CC, Sutliff VE, Yu F, Serrano J, Venzon DJ, Jensen RT: Bone metastases in patients with gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and MRI in their detection, their frequency, location and effect of their detection on management. J Clin Oncol 1998;16:1040-1053.
66. Meijer WG, van der Veer E, Jager PL, van der Jagt EJ, Piers BA, Kema IP, de Vries EGE, Willemse PHB: Bone metastases in carcinoid tumors: Clinical features, imaging characteristics, and markers of bone metabolism. J Nucl Med 2003;44:184-191.
67. Lebtahi R, Cadiot G, Delahaye N, Genin R, Daou D, Peker MC, Chosidow D, Faraggi M, Mignon M, LeGuludec D: Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy. J Nucl Med 1999;40:1602-1608.
68. Hubalewska-Dydejczyk A, Szybinski P, Fross-Baron K, Mikolajczak R, Huszno B, Sowa-Staszczak A: (99m)Tc-EDDA/HYNIC-octreotate: a new radiotracer for detection and staging of NET: a case of metastatic duodenal carcinoid. Nucl Med Rev Cent East Eur 2005;8:155-156.
69. Taal BG, Smits M: Developments in diagnosis and treatment of metastatic midgut carcinoid tumors: a review. Minerva Gastroenterol Dietol 2005;51:335-344.
70. Oo TH, Aish LS, Schneider D, Hassoun H: Carcinoid tumor presenting with bone marrow metastases. J Clin Oncol 2003;21:2995-2996.
71. Zuetenhorst JM, Hoefnageli CA, Boot H, Valdes Olmos RA, Taal BG: Evaluation of (111)In-pentetreotide, (131)I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease. Nucl Med Commun 2002;23:735-741.
72. Goebel SU, Serrano J, Yu F, Gibril F, Venzon DJ, Jensen RT: Prospective study of the value of serum chromogranin A or serum gastrin levels in assessment of the presence, extent, or growth of gastrinomas. Cancer 1999;85:1470-1483.
73. Nikou GC, Toubanakis C, Nikolaou P, Giannatou E, Marinou K, Safioleas M, Karamanolis D: Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients. Hepatogastroenterology 2005;52:1668-1676.
74. Tanaka S, Yamasaki S, Matsushita S, Ozawa Y, Kurosaki A, Takeuchi K, Hoshihara Y, Doi T, Watanabe G, Kawaminami K: Duodenal somatostatinoma: a case report and review of 31 cases with special reference to the relationship between tumor size and metastasis. Pathol Int 2000;50:146-152.
75. Barbareschi M, Frigo B, Aldovini D, Leonardi E, Cristina S, Falleni M: Duodenal gangliocytic paraganglioma. Report of a case and review of the literature. Virchows Arch [A] 1989;416:81-89.
76. Altavilla G, Chiarelli S, Fassina A: Duodenal periampullary gangliocytic paraganglioma: report of two cases with immunohistochemical and ultrastructural study. Ultrastruct Pathol 2001;25:137-145.
77. Sata N, Tsukahara M, Koizumi M, Yoshizawa K, Kurihara K, Nagai H, Someya T, Saito K: Primary small-cell neuroendocrine carcinoma of the duodenum: a case report and review of literature. World J Surg Oncol 2004;2:28.
78. Pyun DK, Moon G, Han J, Kim MH, Lee SS, Seo DW, Lee SK: A carcinoid tumor of the ampulla of Vater treated by endoscopic snare papillectomy. Korean J Intern Med 2004;19:257-260.
79. Bowers SP, Smith CD: Laparoscopic resection of posterior duodenal bulb carcinoid tumor. Am Surg 2003;69:792-795.
80. Perng CL, Lin HJ, Wang K, Lai CR, Lee SD: Treatment of duodenal carcinoid by strip biopsy. J Clin Gastroenterol 1995;20:168-171.
81. Sato T, Fukunaga T, Ohyama S, Ueno M, Oya M, Yamamoto J, Saiura A, Yamaguchi T, Muto T, Kato Y: Endoscopic total layer resection with laparoscopic sentinel node dissection and defect closure for duodenal carcinoid. Hepatogastroenterology 2005;52:678-679.
82. Horsley GW, Golden BN: Carcinoid tumors of the duodenum. Surg Gynecol Obstet 1957;105:417-424.
83. Thompson GB, Van Heerden JA, Martin JK Jr, Schutt AJ, Ilstrup DM, Carney JA: Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis. Surgery 1985;98:1054-1063.
84. Toyonaga T, Nakamura K, Araki Y, Shimura H, Tanaka M: Laparoscopic treatment of duodenal carcinoid tumor: wedge resection of the duodenal bulb under endoscopic control. Surg Endosc 1998;12:1085-1087.
85. Blanc P, Porcheron J, Pages A, Breton C, Mosnier JF, Balique JG: Laparoscopic excision of a duodenal neuroendocrine tumor. Ann Chir 2000;125:176-178.
86. Yamamoto C, Aoyagi K, Suekane H, Iida M, Hizawa K, Kuwano Y, Nakamura S, Fujishima M: Carcinoid tumors of the duodenum: report of three cases treated by endoscopic resection. Endoscopy 1997;29:218-221.
87. Sugg SL, Norton JA, Fraker DL, Metz DC, Pisegna JR, Fishbeyn V, Benya RV, Shawker TH, Doppman JL, Jensen RT: A prospective study of intraoperative methods to diagnose and resect duodenal gastrinomas. Ann Surg 1993;218:138-144.
88. Norton JA, Doppman JL, Collen MJ, Harmon JW, Maton PN, Gardner JD, Jensen RT: Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome. Ann Surg 1986;204:468-479.
89. Yoshikane H, Tsukamoto Y, Niwa Y, Goto H, Hase S, Mizutani K, Nakamura T: Carcinoid tumors of the gastrointestinal tract: evaluation with endoscopic ultrasonography. Gastrointest Endosc 1993;39:375-383.
90. Krenning EP, Kwekkeboom DJ, Valkema R, Pauwels S, Kvols LK, de Jong M: Peptide receptor radionuclide therapy. Ann NY Acad Sci 2004;1014:234-245.
91. deJong M, Kwekkeboom D, Valkema R, Krenning EP: Radiolabelled peptides for tumour therapy: current status and future directions Plenary lecture at the EANM 2002. Eur J Nucl Med Mol Imaging 2003;30:463-469.
92. Kwekkeboom DJ, Mueller-Brand J, Paga nelli G, Anthony LB, Pauwels S, Kvols LK, O'Dorisio TM, Valkema R, Bodei L, Chinol M, Maecke HR, Krenning EP: Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs. J Nucl Med 2005;46(suppl 1):62S-66S.
93. Valkema R, Pauwels S, Kvols LK, Barone R, Jamar F, Bakker WH, Kwekkeboom DJ, Bouterfa H, Krenning EP: Survival and response after peptide receptor radionuclide therapy with [(90)Y-DOTA(0),Tyr(3)]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors. Semin Nucl Med 2006;36:147-156.
94. Kwekkeboom DJ, Teunissen JJ, Bakker WH, Kooij PP, de Herder WW, Feelders RA, van Eijck CH, Esser JP, Kam BL, Krenning EP: Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors. J Clin Oncol 2005;23:2754-2762.